Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Trillium Therapeutics Inc. (TRIL) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/19/2021 4 Walker Paul Edward (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 5,736,363 shares @ $0
Disposed/sold 850,000 options to buy @ $0.96, valued at $816k
Disposed/sold 6,750,000 options to buy @ $0
Disposed/sold 5,400,000 options to buy @ $0.96, valued at $5.2M
Disposed/sold 40,000 options to buy @ $12.03, valued at $481.2k
11/19/2021 4 Pucci Paolo (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 67,000 options to buy @ $15.5, valued at $1M
11/19/2021 4 Myers Scott Dunseth (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 67,000 options to buy @ $9.51, valued at $637.2k
11/19/2021 4 Harrison Rosemary (See Remarks) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 75 shares @ $0
Disposed/sold 180,000 options to buy @ $14.11, valued at $2.5M
11/19/2021 4 BESHAR LUKE M (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 40,000 options to buy @ $12.03, valued at $481.2k
Disposed/sold 6,666 options to buy @ $0
Disposed/sold 547,656 restricted stock units @ $0
11/19/2021 4 Parsons James T. (CFO) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 180,000 options to buy @ $12.03, valued at $2.2M
Disposed/sold 94,792 options to buy @ $0
Disposed/sold 59,896 options to buy @ $0
Disposed/sold 5,761 options to buy @ $0
Disposed/sold 36,204 options to buy @ $0
Disposed/sold 24,390 options to buy @ $0
Disposed/sold 30,171 options to buy @ $0
11/19/2021 4 Kamarck Michael E. (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 67,000 options to buy @ $14.77, valued at $989.6k
11/19/2021 4 Looker Benjamin (General Counsel) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 190,000 options to buy @ $9.51, valued at $1.8M
11/19/2021 4 MACKEY CATHERINE J (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 67,000 options to buy @ $9.7, valued at $649.9k
11/19/2021 4 Bruns Ingmar (Chief Medical Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 400,000 options to buy @ $14.11, valued at $5.6M
11/19/2021 4 Petrova Penka (Chief Development Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 38,808 options to buy @ $0
Disposed/sold 4,574 options to buy @ $0
Disposed/sold 49,480 options to buy @ $0
Disposed/sold 83,960 options to buy @ $0
Disposed/sold 140,000 options to buy @ $12.03, valued at $1.7M
11/19/2021 4 Uger Robert (Chief Scientific Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 102,083 options to buy @ $0
Disposed/sold 58,333 options to buy @ $0
Disposed/sold 5,260 options to buy @ $0
Disposed/sold 23,473 options to buy @ $0
Disposed/sold 29,073 options to buy @ $0
Disposed/sold 250,000 options to buy @ $12.03, valued at $3M
11/19/2021 4 TAYTON-MARTIN HELEN KATRINA (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 40,000 options to buy @ $12.03, valued at $481.2k
Disposed/sold 498,294 restricted stock units @ $0
11/19/2021 4 Skvarka Jan (President and CEO) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Disposed/sold 197,000 options to buy @ $0
Disposed/sold 1,162,500 options to buy @ $0
Disposed/sold 600,000 options to buy @ $12.03, valued at $7.2M
07/09/2021 4 Uger Robert (Chief Scientific Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 3,646 shares @ $0.3039, valued at $1.1k
Sold 3,646 shares @ $9, valued at $32.8k
Exercised 3,646 options to buy @ $0
07/02/2021 4 MACKEY CATHERINE J (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Granted 67,000 options to buy @ $9.7, valued at $649.9k
07/02/2021 3 MACKEY CATHERINE J (Director) has filed a Form 3 on Trillium Therapeutics Inc.
06/09/2021 4 Uger Robert (Chief Scientific Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 3,646 shares @ $0.315, valued at $1.1k
Sold 3,646 shares @ $8.27, valued at $30.2k
Exercised 3,646 options to buy @ $0
05/13/2021 4 Skvarka Jan (President and CEO) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 87,500 shares @ $0.4462, valued at $39k
Exercised 19,198 shares @ $0.314, valued at $6k
Sold 106,698 shares @ $9.2017, valued at $981.8k
Exercised 23,802 shares @ $0.314, valued at $7.5k
Sold 23,802 shares @ $9.2379, valued at $219.9k
Exercised 87,500 options to buy @ $0
Exercised 19,198 options to buy @ $0
Exercised 23,802 options to buy @ $0
05/11/2021 4 Uger Robert (Chief Scientific Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 3,646 shares @ $0.313, valued at $1.1k
Sold 3,646 shares @ $9.3, valued at $33.9k
Exercised 3,646 options to buy @ $0
05/05/2021 4 Looker Benjamin (General Counsel) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Granted 190,000 options to buy @ $9.51, valued at $1.8M
05/05/2021 4 Myers Scott Dunseth (Director) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Granted 67,000 options to buy @ $9.51, valued at $637.2k
05/05/2021 3 Looker Benjamin (General Counsel) has filed a Form 3 on Trillium Therapeutics Inc.
05/05/2021 3 Myers Scott Dunseth (Director) has filed a Form 3 on Trillium Therapeutics Inc.
04/09/2021 4 Uger Robert (Chief Scientific Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 3,646 shares @ $0.3012, valued at $1.1k
Sold 3,646 shares @ $10.82, valued at $39.4k
Exercised 3,646 options to buy @ $0
04/09/2021 4 Petrova Penka (Chief Development Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 2,708 shares @ $0.3022, valued at $818.4
Exercised 2,604 shares @ $3.3638, valued at $8.8k
Sold 5,312 shares @ $11.09, valued at $58.9k
Exercised 2,708 options to buy @ $0
Exercised 2,604 options to buy @ $0
03/15/2021 4 Uger Robert (Chief Scientific Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 2,917 shares @ $3.3924, valued at $9.9k
Sold 2,917 shares @ $11.97, valued at $34.9k
Exercised 2,917 options to buy @ $0
03/12/2021 4 Petrova Penka (Chief Development Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 2,708 shares @ $0.3012, valued at $815.6
Exercised 2,604 shares @ $3.3524, valued at $8.7k
Sold 5,312 shares @ $11.08, valued at $58.9k
Exercised 2,708 options to buy @ $0
Exercised 2,604 options to buy @ $0
03/10/2021 4 Uger Robert (Chief Scientific Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 3,646 shares @ $0.2999, valued at $1.1k
Sold 3,646 shares @ $10.11, valued at $36.9k
Exercised 3,646 options to buy @ $0
02/10/2021 4 Petrova Penka (Chief Development Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 2,708 shares @ $0.2977, valued at $806.2
Exercised 2,604 shares @ $3.3137, valued at $8.6k
Sold 5,312 shares @ $12.65, valued at $67.2k
Exercised 508 shares @ $9.6213, valued at $4.9k
Sold 508 shares @ $14.174, valued at $7.2k
Exercised 2,708 options to buy @ $0
Exercised 2,604 options to buy @ $0
Exercised 508 options to buy @ $0
02/10/2021 4 Uger Robert (Chief Scientific Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 3,646 shares @ $0.2977, valued at $1.1k
Exercised 2,917 shares @ $3.3137, valued at $9.7k
Sold 6,563 shares @ $12.65, valued at $83k
Exercised 584 shares @ $9.6213, valued at $5.6k
Sold 584 shares @ $14.124, valued at $8.2k
Exercised 3,646 options to buy @ $0
Exercised 2,917 options to buy @ $0
Exercised 584 options to buy @ $0
01/15/2021 4 Skvarka Jan (President and CEO) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 5,419 shares @ $0.4248, valued at $2.3k
Sold 5,419 shares @ $15.0411, valued at $81.5k
Exercised 19,581 shares @ $0.4275, valued at $8.4k
Sold 19,581 shares @ $15.0288, valued at $294.3k
Exercised 5,419 options to buy @ $0
Exercised 19,581 options to buy @ $0
01/13/2021 4 Uger Robert (Chief Scientific Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 584 shares @ $9.5671, valued at $5.6k
Sold 584 shares @ $15.2032, valued at $8.9k
Exercised 584 options to buy @ $0
01/13/2021 4 Petrova Penka (Chief Development Officer) has filed a Form 4 on Trillium Therapeutics Inc.
Txns: Exercised 508 shares @ $9.5671, valued at $4.9k
Sold 508 shares @ $15.2073, valued at $7.7k
Exercised 508 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy